Oral microbiome in esophageal adenocarcinoma
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
About this CDAS Project
PLCO (Learn more about this study)
Oral microbiome in esophageal adenocarcinoma
While the incidence of most major cancers appear stable or declining, the incidence of esophageal adenocarcinoma (EA) has increased 6-fold in the U.S. since the 1970s for reasons unknown. Known risk factors for EA are cigarette smoking, obesity, and reflux esophagitis; however, these factors do not completely explain this emerging public health burden. It is urgent to improve our understanding of EA etiology and find out ways to prevent this disease. We hypothesize that the oral microbiome contributes to the development of esophageal adenocarcinoma based on several lines of evidence from our preliminary case control studies: i) there is a global alteration of foregut microbiome in esophageal adenocarcinoma with the strongest changes found in the oral microbiome, ii) commensal oral bacteria are capable of activating or degrading carcinogens in cigarette smoke, and iii) the oral microbiome has potential predictive power for development of oral cancer in the NIH-PLCO cohort. These data suggest that alterations of oral microbiome could contribute to cancer development locally (oral cavity) and downstream (esophagus). The PLCO pre-diagnostic buccal cell samples are an indispensable resource in the next step of esophageal cancer microbiome study because: These PLCO pre-diagnostic buccal cell samples are an indispensable resource in the next step of esophageal cancer microbiome study because: i) We have evaluated the quality of the PLCO samples and found that the samples collected years ago still contain sufficient microbial genetic materials needed for oral microbiome profiling (see section C2), ii) We have compared microbiome alterations in esophageal diseases in the mouth, esophagus, and stomach and found the strongest phenotype association was in the mouth (see section C1), iii) use of the samples collected prior to cancer diagnosis allows us to examine whether microbiome changes precede to cancer development, and iv) use of already collected samples and diet and demographic information in this high quality cohort makes this study cost efficient. We propose a prospective study to resolve the temporal order and etiological relationship between changes in microbiome and development of EA using pre-diagnostic buccal cell samples collected in the NCI-PLCO trial and American Cancer Society Cancer Prevention Study II (ACS-CPS II). This will be a nested case control study including 106 incident esophageal adenocarcinoma cases and 212 controls. We will identify bacterial taxa (Aim 1), bacterial genes/pathways (Aim 2), and non- bacterial microorganisms (viruses, fungi, Archaea) (Aim 3) associated with risk for development of esophageal adenocarcinoma. Using this information, we will construct a panel of integrated biomarkers to predict risk of development of esophageal adenocarcinoma. Knowledge gained from this study could add a new dimension, i.e., microbial risk factors, to our understanding of the etiology and recent surge of esophageal adenocarcinoma. If identified, these pre-diagnostic microbial biomarkers could be used to stratify at-risk subjects into high and low risk groups for more efficient screening and early detection of EA. Normalization of the microbiome in at-risk patients could become a new means for preventing esophageal adenocarcinoma. PUBLIC HEALTH RELEVANCE: The incidence of esophageal adenocarcinoma has increased 6-fold in the U.S. since the 1970s for reasons unknown. We will examine whether indigenous oral microbes contribute to the development of esophageal adenocarcinoma. Knowledge gained from this study could add a new dimension, i.e., microbial risk factors, to our understanding of the etiology and recent surge of esophageal adenocarcinoma, and may lead to more efficient screening, early detection and prevention of esophageal adenocarcinoma.
Approved Addenda This project has one or more approved addenda.
- Shotgun sequencing of newly available cases and matched controls and replacement cases and/or controls in sets issued that had insufficient DNA
Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
Yang L, Hao Y, Hu J, Kelly D, Li H, Brown S, Tasker C, Roche NE, Chang TL, Pei Z
Emerg Microbes Infect. 2019; Volume 8 (Issue 1): Pages 197-210 PUBMED
Mitochondrial somatic mutations and the lack of viral genomic variation in recurrent respiratory papillomatosis.
Hao Y, Ruiz R, Yang L, Neto AG, Amin MR, Kelly D, Achlatis S, Roof S, Bing R, Kannan K, Brown SM, Pei Z, Branski RC
Sci Rep. 2019 Nov 12; Volume 9 (Issue 1): Pages 16625 PUBMED
MGS-Fast: Metagenomic shotgun data fast annotation using microbial gene catalogs.
Brown SM, Chen H, Hao Y, Laungani BP, Ali TA, Dong C, Lijeron C, Kim B, Wultsch C, Pei Z, Krampis K
Gigascience. 2019 Apr; Volume 8 (Issue 4) PUBMED
Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.
Ganly I, Yang L, Giese RA, Hao Y, Nossa CW, Morris LGT, Rosenthal M, Migliacci J, Kelly D, Tseng W, Hu J, Li H, Brown S, Pei Z
Int. J. Cancer. 2019 Jan PUBMED
Association of Coffee and Tea Intake with the Oral Microbiome: Results from a Large Cross-Sectional Study.
Peters BA, McCullough ML, Purdue MP, Freedman ND, Um CY, Gapstur SM, Hayes RB, Ahn J
Cancer Epidemiol. Biomarkers Prev. 2018; Volume 27 (Issue 7): Pages 814-821 PUBMED
Drinking alcohol is associated with variation in the human oral microbiome in a large study of American adults.
Fan X, Peters BA, Jacobs EJ, Gapstur SM, Purdue MP, Freedman ND, Alekseyenko AV, Wu J, Yang L, Pei Z, Hayes RB, Ahn J
Microbiome. 2018; Volume 6 (Issue 1): Pages 59 PUBMED
HPViewer: sensitive and specific genotyping of human papillomavirus in metagenomic DNA.
Hao Y, Yang L, Galvao Neto A, Amin MR, Kelly D, Brown SM, Branski RC, Pei Z
Bioinformatics. 2018; Volume 34 (Issue 12): Pages 1986-1995 PUBMED
55-year-old man with ulcers in inguinal fold and intergluteal cleft found to have systemic Langerhans cell histiocytosis.
Mu EW, Khurram NA, Pei Z, Feng H, Cassai N, Meehan SA, Latkowski JA
JAAD Case Rep. 2018 Sep; Volume 4 (Issue 8): Pages 837-840 PUBMED
A taxonomic signature of obesity in a large study of American adults.
Peters BA, Shapiro JA, Church TR, Miller G, Trinh-Shevrin C, Yuen E, Friedlander C, Hayes RB, Ahn J
Sci Rep. 2018 Jun; Volume 8 (Issue 1): Pages 9749 PUBMED
A multivariate distance-based analytic framework for microbial interdependence association test in longitudinal study.
Zhang Y, Han SW, Cox LM, Li H
Genet. Epidemiol. 2017; Volume 41 (Issue 8): Pages 769-778 PUBMED
A powerful microbiome-based association test and a microbial taxa discovery framework for comprehensive association mapping.
Koh H, Blaser MJ, Li H
Microbiome. 2017; Volume 5 (Issue 1): Pages 45 PUBMED
Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.
Tang MS, Bowcutt R, Leung JM, Wolff MJ, Gundra UM, Hudesman D, Malter LB, Poles MA, Chen LA, Pei Z, Neto AG, Abidi WM, Ullman T, Mayer L, Bonneau RA, Cho I, Loke P
Inflamm. Bowel Dis. 2017; Volume 23 (Issue 9): Pages 1544-1554 PUBMED
Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers.
Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB, Ahn J
Cancer Res. 2017; Volume 77 (Issue 23): Pages 6777-6787 PUBMED
The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study.
Peters BA, Wu J, Hayes RB, Ahn J
BMC Microbiol. 2017 Jul; Volume 17 (Issue 1): Pages 157 PUBMED
"Nature versus Nurture" and the indigenous microbiome.
Hickman RA, Yang L, Pei Z
J Public Health Emerg. 2017 Mar; Volume 1 PUBMED
Cigarette smoking and the oral microbiome in a large study of American adults.
Wu J, Peters BA, Dominianni C, Zhang Y, Pei Z, Yang L, Ma Y, Purdue MP, Jacobs EJ, Gapstur SM, Li H, Alekseyenko AV, Hayes RB, Ahn J
ISME J. 2016; Volume 10 (Issue 10): Pages 2435-46 PUBMED
Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature review.
Guma S, Maglantay R, Lau R, Wieczorek R, Melamed J, Deng FM, Zhou M, Makarov D, Lee P, Pincus MR, Pei ZH
Am J Clin Exp Urol. 2016; Volume 4 (Issue 1): Pages 12-6 PUBMED
The gut microbiota in conventional and serrated precursors of colorectal cancer.
Peters BA, Dominianni C, Shapiro JA, Church TR, Wu J, Miller G, Yuen E, Freiman H, Lustbader I, Salik J, Friedlander C, Hayes RB, Ahn J
Microbiome. 2016; Volume 4 (Issue 1): Pages 69 PUBMED
A rare case of anal carcinosarcoma with human papilloma virus infection in both biphasic tumor elements: An immunohistochemical, molecular and ultrastructural study.
Hickman RA, Bradshaw AD, Cassai N, Neto AG, Zhou D, Fu T, Lee P, Pei Z, Wieczorek R
Papillomavirus Res. 2016 Dec; Volume 2: Pages 164-166 PUBMED
Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.
Neto AG, Whitaker A, Pei Z
Semin. Oncol. 2016 Feb; Volume 43 (Issue 1): Pages 86-96 PUBMED
Erratum to: The first microbial environment of infants born by C-section: the operating room microbes.
Shin H, Pei Z, Martinez KA, Rivera-Vinas JI, Mendez K, Cavallin H, Dominguez-Bello MG
Microbiome. 2016 Jan; Volume 4: Pages 4 PUBMED
HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria.
Yang L, Poles MA, Fisch GS, Ma Y, Nossa C, Phelan JA, Pei Z
AIDS. 2016 Jan; Volume 30 (Issue 1): Pages 19-29 PUBMED
Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response.
Ren W, Ma Y, Yang L, Gettie A, Salas J, Russell K, Blanchard J, Davidow A, Pei Z, Chang TL, Cheng-Mayer C
AIDS. 2015 Jun; Volume 29 (Issue 10): Pages F1-8 PUBMED
Microbiome in reflux disorders and esophageal adenocarcinoma.
Yang L, Chaudhary N, Baghdadi J, Pei Z
Cancer J. 2014; Volume 20 (Issue 3): Pages 207-10 PUBMED
Beyond infectious disease: welcome to the era of population microbiology.
Pincus MR, Pei Z
Clin. Lab. Med. 2014 Dec; Volume 34 (Issue 4): Pages xi-xiii PUBMED
Microbiome, innate immunity, and esophageal adenocarcinoma.
Baghdadi J, Chaudhary N, Pei Z, Yang L
Clin. Lab. Med. 2014 Dec; Volume 34 (Issue 4): Pages 721-32 PUBMED
The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis.
Cho M, Carter J, Harari S, Pei Z
Clin. Lab. Med. 2014 Dec; Volume 34 (Issue 4): Pages 699-710 PUBMED
Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets.
Ma Y, Madupu R, Karaoz U, Nossa CW, Yang L, Yooseph S, Yachimski PS, Brodie EL, Nelson KE, Pei Z
J. Virol. 2014 May; Volume 88 (Issue 9): Pages 4786-97 PUBMED
Mini-review: perspective of the microbiome in the pathogenesis of urothelial carcinoma.
Xu W, Yang L, Lee P, Huang WC, Nossa C, Ma Y, Deng FM, Zhou M, Melamed J, Pei Z
Am J Clin Exp Urol. 2014 Apr; Volume 2 (Issue 1): Pages 57-61 PUBMED